These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22975663)

  • 41. Radiotherapy alone vs. radiochemotherapy in patients with favorable prognosis of clinical stage IIIA non-small-cell lung cancer.
    Jeremić B; Miličić B; Milisavljević S
    Clin Lung Cancer; 2013 Mar; 14(2):172-80. PubMed ID: 23291254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Retrospective analysis of patients with small cell lung cancer treated at Gazi University Department of Radiation Oncology].
    Erpolat OP; Göksel F; Bora H; Akmansu M; Unsal D; Oztürk C; Egehan I; Aşikoğlu H
    Tuberk Toraks; 2005; 53(2):139-47. PubMed ID: 16100650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.
    Sekine I; Sumi M; Ito Y; Horinouchi H; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Kubota K; Tamura T
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):953-9. PubMed ID: 21377282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.
    Takayama K; Inoue K; Tokunaga S; Matsumoto T; Oshima T; Kawasaki M; Imanaga T; Kuba M; Takeshita M; Harada T; Shioyama Y; Nakanishi Y
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1353-9. PubMed ID: 24166107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
    Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
    Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
    Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
    Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of superior sulcus tumors: results and prognostic factors.
    Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
    Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
    Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Kesarwala AH; Lu DJ; Xanthopoulos E; Apisarnthanarax S; Cengel KA; Evans TL; Aggarwal C; Cohen RB; Langer CJ; Rengan R; Simone CB
    Clin Lung Cancer; 2018 Mar; 19(2):e205-e209. PubMed ID: 29153967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy.
    Kim BH; Chung JH; Son J; Kim S; Wu HG; Kim HJ
    Cancer Res Treat; 2023 Jan; 55(1):73-82. PubMed ID: 35287254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between the SER treatment period and prognosis of patients with small cell lung cancer.
    Xiao XG; Wang SJ; Hu LY; Chu Q; Wei Y; Li Y; Mei Q; Chen Y
    Asian Pac J Cancer Prev; 2014; 15(15):6415-9. PubMed ID: 25124635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and Its Impact on Survival.
    Lee K; Kloecker G; Pan J; Rai S; Dunlap NE
    Am J Clin Oncol; 2015 Oct; 38(5):448-56. PubMed ID: 24064751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.
    Rades D; Kaesmann L; Janssen S; Schild SE
    Lung; 2016 Aug; 194(4):625-9. PubMed ID: 27140191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A relapse of small-cell lung cancer ten years after concomitant chemoradiotherapy followed by high-dose chemotherapy with autologous peripheral blood stem cell transfusion].
    Taniguchi A; Takigawa N; Hotta K; Matsumura T; Tanimoto M; Kiura K
    Nihon Kokyuki Gakkai Zasshi; 2011 Sep; 49(9):697-701. PubMed ID: 22073618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
    Ohara S; Kanda S; Okuma H; Goto Y; Horinouchi H; Fujiwara Y; Nokihara H; Ito Y; Yamamoto N; Usui K; Homma S; Ohe Y
    Jpn J Clin Oncol; 2018 Jan; 48(1):82-88. PubMed ID: 29136177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.